Home
Conditions
Refractory Chronic Lymphocytic Leukemia

Clinical trial condition

Refractory Chronic Lymphocytic Leukemia

Explore clinical trials studying Refractory Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

109 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Refractory Chronic Lymphocytic Leukemia trial results

Active, Not Recruiting

Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

NCT02756897

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +19 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT03277729

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +43 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia

NCT02427451

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Lenalidomide, Ibrutinib, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma That Is Metastatic or Cannot Be Removed by Surgery

NCT02160015

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Active, Not Recruiting

Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma

NCT03479268

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Disease Attributes, +40 more
Locations: City of Hope Medical Center Duarte, California, United States

Roswell Park Comprehensive Cancer Center Buffalo, New York, United States

View Trial Details

Active, Not Recruiting

Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL

NCT04624633

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, Not Recruiting

Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT03961672

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations: City of Hope Medical Center Duarte, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Active, Not Recruiting

Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia

NCT04007029

Conditions: CD19 Positive, CD20 Positive, Chronic Disease, +33 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Refractory Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia trial results

Related conditions